Court Halts Mail-Order Abortion Pills

Appeals Court Blocks Mail Abortion Pills A U.S. federal appeals court on Friday, May 1, 2026, temporarily reinstated a nationwide requirement for abortion pills to be obtained in person, impacting access to medication abortion across the United States. This ruling by the 5th U.S. Circuit Court of Appeals reverses a 2023 Biden administration rule that allowed mifepristone, one of two drugs used in medication abortion, to be dispensed via mail after telehealth consultations.

The decision stems from a lawsuit filed by Louisiana against the U.S. Food and Drug Administration (FDA). The court's opinion, written by Trump-appointed Circuit Judge Kyle Duncan, stated that current federal regulations enable out-of-state prescribers to circumvent Louisiana's abortion laws. Medication abortion currently accounts for approximately two-thirds of all abortions in the United States.

The ruling undermines a method of abortion that has become more prevalent since the U.S. Supreme Court overturned Roe v. Wade in 2022. Data from #WeCount indicates that over 1 in 4 abortions nationwide were provided through telehealth in the first half of 2025, an increase from less than 1 in 10 in 2022. This legal development represents a significant victory for the anti-abortion movement and is the latest in a series of legal challenges concerning abortion pill access.